Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway

Autor: Yan Zhuang, Shigeki Saito, Martina Korfei, Bin Shan, Fayong Luo, Andreas Guenther, Svitlana Danchuk, Joseph A. Lasky
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
Protein Expression
mTORC1
Biochemistry
Idiopathic pulmonary fibrosis
Transforming Growth Factor beta
Animal Cells
Pulmonary fibrosis
Phosphoprotein Phosphatases
Medicine
lcsh:Science
Lung
Connective Tissue Cells
Aged
80 and over

TOR Serine-Threonine Kinases
Chemical Reactions
3. Good health
Physical Sciences
Cellular Types
Molecular Probe Techniques
Bleomycin
03 medical and health sciences
Humans
RNA
Messenger

Molecular Biology Techniques
Molecular Biology
Aged
Molecular Biology Assays and Analysis Techniques
Ribosomal Protein S6 Kinases
lcsh:R
Biology and Life Sciences
Proteins
Fibroblasts
medicine.disease
respiratory tract diseases
Biological Tissue
030104 developmental biology
chemistry
Multiprotein Complexes
lcsh:Q
Developmental Biology
Vascular Endothelial Growth Factor A
0301 basic medicine
Indoles
Pulmonary Fibrosis
lcsh:Medicine
Histone Deacetylase 6
Hydroxamic Acids
Phosphatidylinositol 3-Kinases
chemistry.chemical_compound
Tubulin
Medicine and Health Sciences
Phosphorylation
Post-Translational Modification
Mice
Knockout

Multidisciplinary
Cell Death
biology
Nuclear Proteins
Acetylation
Animal Models
Middle Aged
respiratory system
Chemistry
medicine.anatomical_structure
Experimental Organism Systems
Connective Tissue
Cell Processes
Female
Anatomy
Signal Transduction
Research Article
Autophagic Cell Death
Immunoblotting
Mouse Models
Mechanistic Target of Rapamycin Complex 1
Research and Analysis Methods
Collagen Type I
Histone Deacetylases
Model Organisms
Autophagy
Gene Expression and Vector Techniques
Animals
PI3K/AKT/mTOR pathway
business.industry
Autophagosomes
Cell Biology
Transforming growth factor beta
HDAC6
Hypoxia-Inducible Factor 1
alpha Subunit

Fibrosis
Idiopathic Pulmonary Fibrosis
biology.protein
Cancer research
business
Proto-Oncogene Proteins c-akt
Collagens
Zdroj: PLoS ONE, Vol 12, Iss 10, p e0186615 (2017)
PLoS ONE
ISSN: 1932-6203
Popis: Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal disease. Histone deacetylase 6 (HDAC6) alters function and fate of various proteins via deacetylation of lysine residues, and is implicated in TGF-β1-induced EMT (epithelial-mesenchymal transition). However, the role of HDAC6 in pulmonary fibrosis is unknown. Methods HDAC6 expression in IPF and control lungs was assessed by quantitative real-time PCR (qRT-PCR) and immunoblots. Lung fibroblasts were treated with TGF-β1 ± HDAC6 inhibitors (Tubacin, Tubastatin, ACY1215, or MC1568), and fibrotic markers such as type I collagen were assessed using qRT-PCR and immunoblots. Mice were treated with bleomycin (oropharyngeal aspiration; single dose) ± Tubastatin (intraperitoneally injection; daily for 21 days), and lung collagen expression was gauged using immunoblots and trichrome staining. In a separate experiment, HDAC6 wild-type (WT) and knockout (KO) mice were administered bleomycin, and lungs were evaluated in the same manner. Results HDAC6 expression was deregulated in IPF lungs. Among the HDAC6 inhibitors tested, only Tubastatin significantly repressed TGF-β1-induced expression of type-1 collagen in lung fibroblasts, and this finding was coupled with decreased Akt phosphorylation and increased Akt-PHLPP (PH domain and Leucine rich repeat Protein Phosphatase) association. Tubastatin repressed TGF-β1-induced S6K phosphorylation, HIF-1α expression, and VEGF expression. Tubastatin also repressed TGF-β1-induced inhibition of LC3B-II (a marker of autophagosome formation). In bleomycin-treated mouse lungs, HDAC6 expression was increased, and Tubastatin repressed type-1 collagen expression. However, in HDAC6 KO mice, bleomycin-induced type-1 collagen expression was not repressed compared to WT mice. Knockdown of HDAC6, as well as HDAC10, another potential Tubastatin target, did not inhibit TGF-β1-induced collagen expression in lung fibroblasts. Conclusions HDAC6 expression is altered during lung fibrogenesis. Tubastatin represses TGF-β1-induced collagen expression, by diminishing Akt phosphorylation and regulating downstream targets such as HIF-1α-VEGF axis and autophagy. Tubastatin-treated WT mice are protected against bleomycin-induced fibrosis, but HDAC6 KO mice are not. Our data suggest that Tubastatin ameliorates pulmonary fibrosis, by targeting the TGFβ-PI3K-Akt pathway, likely via an HDAC6-independent mechanism.
Databáze: OpenAIRE